Related Experiment Video

Updated: May 31, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Targeted therapy of non-small-cell lung carcinoma

Divya Tiwari1, Seth A Brodie, Johann C Brandes

  • 1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

Therapeutic Advances in Respiratory Disease
|July 7, 2011
PubMed

Insights

Novel technologies have improved understanding of lung cancer molecular biology, leading to new targeted therapies. This review covers key pathways and clinical evidence for these lung cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Recent advancements in cancer research technologies have significantly enhanced the understanding of lung cancer's molecular underpinnings.
  • This progress has accelerated the development of novel targeted therapies specifically designed for lung cancer treatment.

Purpose of the Study:

  • To review the critical molecular pathways implicated in lung cancer development and progression.
  • To summarize the existing clinical evidence supporting targeted therapies against these identified molecular targets in lung cancer.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of clinical trial data for targeted lung cancer therapies.
  • Synthesis of information on molecular pathways and their therapeutic relevance.

Main Results:

  • Identification of key molecular pathways driving lung cancer.
  • Compilation of clinical data demonstrating the efficacy of therapies targeting these pathways.
  • Overview of the current landscape of targeted lung cancer treatment strategies.

Conclusions:

  • Targeted therapies based on molecular pathways represent a significant advancement in lung cancer treatment.
  • Continued research into molecular biology is crucial for developing more effective and personalized lung cancer therapies.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.